Nicotinic Receptors and Schizophrenia: Phase II

Trial Profile

Nicotinic Receptors and Schizophrenia: Phase II

Phase of Trial: Phase II

Latest Information Update: 07 Mar 2017

At a glance

  • Drugs GTS 21 (Primary)
  • Indications Schizoaffective disorder; Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Jun 2015 Status changed from recruiting to completed as per record..
    • 01 Feb 2013 Status changed from active, no longer recruiting to recruiting as reported by
    • 29 Sep 2011 Actual initiation date (Jul 2011) added as reported by
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top